Targeting tuberculosis using structure-guided fragment-based drug design (2017)
Attributed to:
Cambridge-Chennai Centre Partnership on Antimicrobial Resistant Tuberculosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.drudis.2016.10.003
PubMed Identifier: 27742535
Publication URI: http://europepmc.org/abstract/MED/27742535
Type: Journal Article/Review
Parent Publication: Drug Discovery Today
Issue: 3
ISSN: 1359-6446